ハイパーアモネミアの成人における臨床的,生化学的,および分子学的発見:フランスの二中心的遡及研究
Julien Maquet1, Clément Pontoizeau2, Apolline Imbard3
1Department of Internal Medicine, Toulouse University hospital, Toulouse, France; Reference Center for Inborn Errors of Metabolism, Toulouse University hospital, G2M Network, Toulouse, France; Reference Center for Inborn Errors of Metabolism, Department of Pediatrics, Necker Hospital, APHP, Université Paris-Cité, G2M Network, MetabERN, Paris, France.
Molecular genetics and metabolism
|August 20, 2025
まとめ
大人における高アンモニア症には様々な原因があり,遺伝的ではなく,しばしば得られたものです. 遺伝代謝疾患 (IMD) の遺伝子検査は,生化学的プロファイルが示唆される場合に最も効果的です.
科学分野:
- 臨床医学
- 遺伝学
- 生物化学
背景:
- ハイパーアモネミアは 昏睡状態や死亡に至る重大な状態であり,迅速な医療介入が必要である.
- 成人におけるハイパーアモネミアの様々な病因を理解することは,効果的な管理に不可欠です.
研究 の 目的:
- 成人患者におけるハイパーアモネミアの原因のスペクトルを定義する.
- この集団における遺伝代謝疾患 (IMD) の特定のための標的型次世代配列化 (NGS) の診断的有用性を評価する.
主な方法:
- 2つの患者群の分析:ハイパーアモネミア (≥100μmol/L) とNGSによるIMDの遺伝子検査を受けた患者群.
- 含有基準は,アンモニア濃度が高い成人患者 (≥15歳) に焦点を当てた.
主要な成果:
- 主要コホート (184人の患者) は,非遺伝的肝不全,移植系統的シャント,陽性因子 (例えばアスパラギナーゼ,バルプロ酸) を含む様々な原因を明らかにした.
- 13人の成人に遺伝代謝疾患 (IMD) が確認された. NGSコホート (17人の患者) では,生化学的プロファイルを示唆する6人の患者のうち5人の遺伝子検査が陽性であった.
- タンパク質の栄養失調は,重度の基礎疾患を有する4人の患者で認められた.
結論:
- 大人のアンモニア高血症の病因は多因性であり,既得的要因と遺伝的要因の両方を含む.
- IMDの標的型NGSは,特に示唆的な生化学的発見によって導かれた場合,有望であるが,特定された既得原因の急性,非特異的なプレゼンテーションでは低収量である.
関連する概念動画
Urea Cycle
45.8K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
45.8K
Inborn Errors of Metabolism
241
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
241
Serum Laboratory Studies, Stool Test, Breath Test
474
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
474
Overview of Protein Metabolism
1.8K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.8K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87


